Treatment of palmoplantar psoriasis with intramuscular alefacept

Journal of the American Academy of Dermatology

Volumn 53, Issue 2 SUPPL., 2005, Pages

  Myers, Wendy ^a   Christiansen, Linda ^a   Gottlieb, Alice B ^a  

^a ROBERT WOOD JOHNSON MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALEFACEPT;

ADULT; ARTICLE; CASE REPORT; CLINICAL FEATURE; DISEASE COURSE; FEMALE; HUMAN; LABORATORY TEST; PRIORITY JOURNAL; PUSTULOSIS PALMOPLANTARIS; QUALITY OF LIFE; TREATMENT OUTCOME;

BIOLOGICAL PRODUCTS; DERMATOLOGIC AGENTS; FEMALE; HUMANS; INJECTIONS, INTRAMUSCULAR; MIDDLE AGED; PSORIASIS; RECOMBINANT FUSION PROTEINS;

EID: 21844456520     PISSN: 01909622     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jaad.2004.12.024     Document Type: Article

References (9)

1. Amevive (alefacept) [package insert] 2003 Biogen Idec Inc Boston
2. G.G. Krueger, and K.P. Callis Development and use of alefacept to treat psoriasis J Am Acad Dermatol 49 2003 S87 S97
3. G.D. Weinstein, and M.A. Menter An overview of psoriasis G.D. Weinstein A.B. Gottlieb Therapy of moderate-to-severe psoriasis 2nd ed. 2003 Marcel Dekker New York 1 29
4. A.A. Pettey, R. Balkrishnan, S.R. Rapp, A.B. Fleischer, and S.R. Feldman Patients with palmoplantar psoriasis have more physical disability and discomfort than patients with other forms of psoriasis: implications for clinical practice J Am Acad Dermatol 49 2003 271 275
5. R.D.R. Camp Textbook of dermatology 1992 Blackwell Publishing Oxford
6. M. Lebwohl New developments in the treatment of psoriasis Arch Dermatol 138 2002 686 688
7. G.G. Krueger, K.A. Papp, D.B. Stough, K.H. Loven, W.P. Gulliver, and C.N. Ellis A randomized, double-blind, placebo-controlled phase III study evaluating efficacy and tolerability of 2 courses of alefacept in patients with chronic plaque psoriasis J Am Acad Dermatol 47 2002 821 833
8. M. Lebwohl, E. Christophers, R. Langley, J.P. Ortonne, J. Roberts, and C.E. Griffiths An international, randomized, double-blind, placebo-controlled phase 3 trial of intramuscular alefacept in patients with chronic plaque psoriasis Arch Dermatol 139 2003 719 727
9. H.K. Bell, and R.A.G. Parslew Use of basiliximab as a cyclosporin-sparing agent in palmoplantar pustular psoriasis with myalgia as an adverse effect Br J Dermatol 147 2002 606 607